Search the Newsreel

Apogee Therapeutics (APGE) CMO trades stock under 10b5-1 plan

Apogee Therapeutics' Chief Medical Officer, Carl Dambkowski, exercised stock options for 4,125 shares at $22.86 per share and simultaneously sold 5,500 shares at $134.17 per share on August 5, 2026. This transaction was conducted under a Rule 10b5-1 trading plan adopted in September 2025. …

Sei Investments Co. Grows Stock Holdings in Apogee Therapeutics Inc. $APGE

Sei Investments Co. significantly increased its stake in Apogee Therapeutics Inc. by 158.5% in the first quarter, bringing its total holdings to 42,203 shares valued at approximately $3.55 million. While institutional ownership of APGE is high at 79.04%, company insiders have sold a substantial …

Apogee Enterprises Inc (APOG) Stock News Today

This page provides current stock news and financial data for Apogee Enterprises Inc (APOG). It includes real-time stock quotes, market capitalization, P/E ratio, and highlights that more news and analysis are coming soon. The stock closed at $43.520 with a slight gain on August …

(APOG) Movement as an Input in Quant Signal Sets

This article analyzes Apogee Enterprises Inc. (APOG) using AI models to generate trading strategies and multi-timeframe signal analysis. It highlights strong near and mid-term sentiment, potential for long-term extension, and identifies compelling upside potential with no resistance levels above the current price. The report …

Apogee Enterprises Inc (APOG) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Apogee Enterprises Inc (APOG), noting its current earnings forecast score and industry ranking. It details analyst ratings, price targets, and expected EPS and revenue figures for upcoming quarters. The consensus among analysts is a "Buy" trend for …

Apollo Global Management (APO) Picks Austin For Its Next Tech Hub, Not M&A

Apollo Global Management (APO) is establishing a new technology and innovation hub in Austin, Texas, to capitalize on the region's hard tech and chip manufacturing ecosystem. CEO Marc Rowan emphasizes organic growth and selective M&A, aligning with the firm's focus on an "industrial renaissance" …

Top stocks in news: LIC, Britannia, TVS Motor, Premier, Dabur, Apollo Tyres, Alkem Labs

APOLLOTYRE Outlook for the Week (August 10, 2026 – August 14, 2026)

PRE-MARKET INDIAN STOCKS NEWS: Earnings including Apollo Tyres, Brittania Industries, Fortis Healthcare and LIC

Eagle Point Credit Management sells Acres Commercial preferred stock for $2,136

Eagle Point Credit Management LLC, a significant owner and director of ACRES Commercial Realty Corp. (NASDAQ:ACR), sold 98 shares of 7.875% Series D Preferred Stock for a total of $2,136 on August 4, 2026. Following this transaction, the firm indirectly retains over 715,000 shares …

Singapore Airlines Limited (SGX:C6L) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Apogee Therapeutics stock hits all-time high at 134.47 USD

Apogee Therapeutics stock has reached an all-time high of $134.47, reflecting a significant 270% 1-year return and a market cap of $10.08 billion. This surge comes as the company is set to be acquired by AbbVie for $135.11 per share, valuing it at approximately …

PMC Files Amended Lawsuit Against Apogee, Wausau and Viracon Over Defective Glass

PMC Property Group has filed an amended lawsuit against Apogee Enterprises and its subsidiaries, Wausau Group and Viracon Inc., alleging defective glass in three Philadelphia high-rise residential buildings. The lawsuit claims the defendants are avoiding responsibility for the spontaneous shattering of windows, which PMC …

HC Wainwright Has Negative Outlook for SPTX FY2026 Earnings

Apogee Therapeutics, Inc. (APGE) Stock Price, News, Quote & History

Apogee Therapeutics, Inc. (APGE) is a clinical-stage biotechnology company focused on developing novel biologics for inflammatory and immunology indications. The article provides current stock performance, key financial metrics, analyst ratings, and a company overview, highlighting its drug candidates like Zumilokibart (APG777) in clinical trials …

Singapore Exchange Limited Reports Earnings Results for the Full Year Ended June 30, 2026

Two Public-Company CEOs Take Seats on Apogee Enterprises' Board

Apogee Enterprises, Inc. (Nasdaq: APOG) has expanded its Board of Directors from six to eight members by appointing Joseph B. Hayek, President and CEO of Worthington Enterprises, Inc., and Suresh Krishna, President and CEO of Proto Labs, Inc., as independent directors. These additions, effective …

Singapore Exchange rings up record earnings, caps year with additional one-off dividend

Seaport Therapeutics (SPTX) insider Steven M. Paul reports 6.3% stake

Steven M. Paul has reported a 6.3% stake in Seaport Therapeutics, Inc. (SPTX) through a Schedule 13G SEC filing. This ownership amounts to 3,516,718 shares of Voting Common Stock, comprising both shares held directly and shares from exercisable stock options. Paul maintains sole voting …

Seaport Therapeutics (SPTX): Daphne Zohar discloses 5.23M-share, 9.1% beneficial stake

Daphne Zohar has reported a beneficial stake of 9.1% in Seaport Therapeutics (SPTX), totaling 5,225,497 shares of Voting Common Stock as of June 30, 2026. This ownership includes both shares held of record and stock options exercisable within 60 days, giving her sole voting …

Fraport-Aktie dennoch verlustreich: Operatives Ergebnis besser als erwartet

Singapore Shares Open Higher as Investors Focus on Earnings

Fraport-Gewinn bricht ein: Verkehrsprobleme in Frankfurt belasten Ergebnis

JonesTrading Issues Positive Forecast for Seaport Entertainment Gr (NYSE:SEG) Stock Price

Seaport Entertainment Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Seaport Entertainment Group Inc. reported its earnings for the second quarter and first six months of 2026. For the second quarter, sales increased to $7.05 million, but revenue decreased to $34.29 million, with a net loss of $10.11 million. For the six months, sales …

Apollo Commercial Real Estate Finance (NYSE:ARI) Cut to Strong Sell at Zacks Research

Zacks Research downgraded Apollo Commercial Real Estate Finance (NYSE:ARI) to a "strong sell" from a "hold" rating, following similar downgrades from other analysts. Despite this, the overall analyst consensus remains a "Hold" with an average price target of $11.33. The stock opened at $6.79, …

This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now

Key Points AbbVie posted solid second-quarter financial results, led by its two most important products, Skyrizi and Rinvoq. The company's portfolio and pipeline should help maintain steady revenue and earnings over the medium term. AbbVie has increased its payouts for over 50 consecutive years. …

Apollo (APO) Stock Premium Faces Pushback Despite Record Fee Earnings

Seaport Entertainment Group (NYSE: SEG) Q2 revenue falls 13.8% as adjusted profit improves

Apogee Enterprises adds two CEOs to board of directors By Investing.com

Apogee Enterprises, Inc. (NASDAQ:APOG) has expanded its board of directors from six to eight members with the appointment of two new independent directors. Joseph B. Hayek, President and CEO of Worthington Enterprises, Inc., and Suresh Krishna, President and CEO of Proto Labs, Inc., have …

UBS Adjusts Price Target on Apollo Global Management to $172 From $157, Maintains Buy Rating

UBS has raised its price target for Apollo Global Management (APO) to $172 from $157, while reiterating a Buy rating on the stock. This adjustment reflects a positive outlook from the analyst firm on the alternative asset manager. The article mentions several other analyst …

Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout

Baron Capital's Baron Health Care Fund exited its position in Apogee Therapeutics (APGE) after the company announced an agreement to be acquired by AbbVie Inc. for $135.11 per share. The acquisition, representing a 49.5% premium, led to the fund selling its shares. Despite this, …

Apollo CEO has a $11.1 billion net worth today—but he started out with a series of hospitality jobs

Marc Rowan, cofounder and CEO of Apollo Global Management, has a net worth of $11.1 billion, but he started his career with various hospitality and retail jobs, including valet parking and working in a party goods store. He emphasizes that these early experiences were …

Dimensional Fund Advisors LP Has $35.67 Million Stock Position in Apogee Enterprises, Inc. $APOG

Dimensional Fund Advisors LP increased its stake in Apogee Enterprises (NASDAQ:APOG) by 7.9% to 1.06 million shares, valuing their position at $35.67 million. The industrial products company exceeded quarterly EPS estimates with $0.57, though revenue saw a slight year-over-year decline. Analysts maintain a "Buy" …

Arrowstreet Capital Limited Partnership Takes $2.66 Million Position in Apogee Enterprises, Inc. $APOG

Arrowstreet Capital Limited Partnership has acquired 79,388 shares of Apogee Enterprises (NASDAQ:APOG), valued at approximately $2.66 million, establishing a new position in the industrial products company. This investment highlights institutional interest, with such investors now owning 94.05% of Apogee. The move follows recent analyst …

Seaport Entertainment Group (NYSE: SEG) posts Q2 loss, sells 250 Water